Загрузка...
SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway
Candida albicans is a ubiquitous clinical fungal pathogen. Prolonged use of the first-line antifungal agent fluconazole (FLC) has intensified fungal resistance and limited its effectiveness for the treatment of fungal infections. The combined administration of drugs has been extensively studied and...
Сохранить в:
| Опубликовано в: : | Front Microbiol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596347/ https://ncbi.nlm.nih.gov/pubmed/33178156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.572608 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|